. Serum levels of transminases were significantly raised in patients with long term occlusion but apart from that, the cirrhotic liver seems to withstand the ischemia/reperfusion insult well. This was studied by tissue blood flow and malondialdehyde levels during ischemia/reperfusion. These two measurements did not indicate any severe ischaemic damage. One explanation for the good tolerance of the liver to ischemia is the retrograde flow of blood from the vena cava in to the hepatic veins alternating with pressure differences in the thoracic cavity. This backflow may contribute to the maintenance of liver function.
There are a few points that I would like to discuss in relation to this paper. Firstly, the benefit of reducing blood loss. In this study there was a significant reduction in blood loss in patients undergoing occlusion compared to those operated with a conventional technique (819 ml vs 1652 ml). Similar findings have been found by others and the postoperative morbidity was, in the latter study, also related to the amount of blood loss. So therefore all measures that can be taken in order to reduce blood loss are of benefit for the postoperative course. Besides inflow occlusion, in situ or surface liver cooling may also further reduce the bleeding as has been shown in another paper
The second issue is the tolerance of the cirrhotic liver to ischemic damage. One most state that there is quite substantional clinical evidence that the cirrhotic liver may tolerate up to more than an hour of warm ischemia. There is also experimental evidence that although the injury is somewhat more pronounced in cirrhotic livers the impact of this in relation to regeneration after resection in minot6'7. In the experimental study on regeneration it is found that the detrimental effect on hepatic regeneration was more due to portal pooling and reperfusion of portal blood than ischemia/reperfusion by itself.
One problem in the preoperative evaluation of patients with liver cirrhosis is how to estimate the amount of ischaemia that can be inflicted on the liver with no harm. The patient group with liver cirrhosis comprises a wide range of functional reserve in relation to operative tolerance to ischemia. This is particularly difficult since we do not know which cell types in the liver are more prone to hypoxia. One group of patients which seems to be at particularly high risk for morbidity is patients with cholestasis. In this group of patients with cirrhosis and cholestasis preoperative drainage prior to resection may be indicated.
In conclusion, patients with cirrhosis can undergo hepatic resection with inflow occlusion with reduced blood loss and thereby reduced morbidity without inflicting any significant ischaemic damage to the liver, if ischaemia time is of one hour duration or less.
